Statements of Stockholders' Equity (Deficit) - USD ($) | Common Stock | Additional Paid-In Capital | Deferred Stock-based Compensation | Accumulated Deficit | Total |
Beginning balance, shares at Dec. 31, 2018 | 36,303,800 | | | | |
Beginning balance, value at Dec. 31, 2018 | $ 3,630 | $ 5,648,270 | $ (829,167) | $ (4,915,203) | $ (92,470) |
Common stock issued for cash, shares | 200,000 | | | | |
Common stock issued for cash, value | $ 20 | $ 99,980 | | | $ 100,000 |
Expense recognition of deferred stock-based compensation | | | 829,167 | | 829,167 |
Net loss | | | | $ (876,661) | $ (876,661) |
Ending balance, shares at Mar. 31, 2019 | 36,503,800 | | | | |
Ending balance, value at Mar. 31, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,791,864) | $ (39,964) |
Beginning balance, shares at Dec. 31, 2018 | 36,303,800 | | | | |
Beginning balance, value at Dec. 31, 2018 | $ 3,630 | $ 5,648,270 | $ (829,167) | $ (4,915,203) | $ (92,470) |
Net loss | | | | | $ (947,319) |
Ending balance, shares at Dec. 31, 2019 | 36,503,800 | | | | |
Ending balance, value at Dec. 31, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,862,522) | $ (110,622) |
Beginning balance, shares at Mar. 31, 2019 | 36,503,800 | | | | |
Beginning balance, value at Mar. 31, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,791,864) | $ (39,964) |
Common stock issued for cash, shares | | | | | |
Common stock issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | (30,875) | (30,875) |
Ending balance, shares at Jun. 30, 2019 | 36,503,800 | | | | |
Ending balance, value at Jun. 30, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,822,739) | $ (70,839) |
Common stock issued for cash, shares | | | | | |
Common stock issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | $ (15,071) | $ (15,071) |
Ending balance, shares at Sep. 30, 2019 | 36,503,800 | | | | |
Ending balance, value at Sep. 30, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,837,810) | $ (85,910) |
Common stock issued for cash, shares | | | | | |
Common stock issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | $ (24,712) | $ (24,712) |
Ending balance, shares at Dec. 31, 2019 | 36,503,800 | | | | |
Ending balance, value at Dec. 31, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,862,522) | $ (110,622) |
Common stock issued for cash, shares | 100,000 | | | | |
Common stock issued for cash, value | $ 10 | $ 9,990 | | | $ 10,000 |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | $ (47,328) | $ (47,328) |
Ending balance, shares at Mar. 31, 2020 | 36,603,800 | | | | |
Ending balance, value at Mar. 31, 2020 | $ 3,660 | $ 5,758,240 | | $ (5,909,850) | $ (147,950) |
Beginning balance, shares at Dec. 31, 2019 | 36,503,800 | | | | |
Beginning balance, value at Dec. 31, 2019 | $ 3,650 | $ 5,748,250 | | $ (5,862,522) | $ (110,622) |
Net loss | | | | | $ (135,168) |
Ending balance, shares at Dec. 31, 2020 | 36,603,800 | | | | |
Ending balance, value at Dec. 31, 2020 | $ 3,660 | $ 5,758,240 | | $ (5,997,690) | $ (235,790) |
Beginning balance, shares at Mar. 31, 2020 | 36,603,800 | | | | |
Beginning balance, value at Mar. 31, 2020 | $ 3,660 | $ 5,758,240 | | $ (5,909,850) | $ (147,950) |
Common stock issued for cash, shares | | | | | |
Common stock issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | $ (37,478) | $ (37,478) |
Ending balance, shares at Jun. 30, 2020 | 36,603,800 | | | | |
Ending balance, value at Jun. 30, 2020 | $ 3,660 | $ 5,758,240 | | $ (5,947,328) | $ (185,428) |
Common stock issued for cash, shares | | | | | |
Common stock issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | $ (24,110) | $ (24,110) |
Ending balance, shares at Sep. 30, 2020 | 36,603,800 | | | | |
Ending balance, value at Sep. 30, 2020 | $ 3,660 | $ 5,758,240 | | $ (5,971,438) | $ (209,538) |
Common stock issued for cash, shares | | | | | |
Common stock issued for cash, value | | | | | |
Expense recognition of deferred stock-based compensation | | | | | |
Net loss | | | | $ (26,252) | $ (26,252) |
Ending balance, shares at Dec. 31, 2020 | 36,603,800 | | | | |
Ending balance, value at Dec. 31, 2020 | $ 3,660 | $ 5,758,240 | | $ (5,997,690) | $ (235,790) |